EVENTS & NEWS
LABRHA at the OARSI Congress / March 31 – April 3 2016

LABRHA at the OARSI Congress / March 31 – April 3 2016

LABRHA participated in the last OARSI Congress which took place from the 31st of March to the 3rd of April 2016 in Amsterdam. The company presented the results of the double-blind, controlled, multicenter, randomized trial conducted on 226 patients and comparing the efficacy and tolerance of HAppyVisc® vs. Euflexxa®.     The related abstract has...
4 presentations for LABRHA at the 3rd Edition of the ISIAT Congress in Budapest last 1-3 October 2015

4 presentations for LABRHA at the 3rd Edition of the ISIAT Congress in Budapest last 1-3 October 2015

LABRHA participated in the 3rd International Symposium on Intra-Articular Treatment (ISIAT) Congress which took place in Budapest last 1-3 October 2015. The following 4 oral communications were presented for the company by Dr. Thierry Conrozier: Safety and efficacy of intra articular injections of a combination of hyaluronic acid and mannitol (HANOX-M) in patients with symptomatic...
LABRHA at the 27th Annual Congress of the French Society of Rheumatology (SFR)

LABRHA at the 27th Annual Congress of the French Society of Rheumatology (SFR)

LABRHA actively participated in the 27th Annual Congress of the French Society of Rheumatology which took place in Paris from 7 to 9 December 2014. LABRHA was present with a booth in the exhibition area (F4-F5) where the company’s innovative portfolio and scientific projects were presented to the medical community. Posters and Oral Communication –...
OARSI, ISIAT, SFR: Our poster presentations and oral communications

OARSI, ISIAT, SFR: Our poster presentations and oral communications

Before publication in a peer-reviewed journal, we communicate and present our work and research findings at important scientific meetings and medical conferences. Several research abstracts have already been displayed and presented on oversized posters at different meetings. Please find them below: CUIVRAMINE DIFFERENTIAL IMPACT OF GLUCOSAMINE SULFATE AND CUIVRAMINE® ON THE IL-1β STIMULATED C-20/A4 CHONDROCYTE...